The Latest Cardiac and Vascular News
Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF) In a Phase 2B clinical trial, the prevalence of clinically important bradycardia was statistically significantly lower for GencaroTM compared to metoprolol WESTMINSTER, Colo., Jan. 04, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical […]
MORRISVILLE, N.C., Jan. 03, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and will continue as a director on the board. He succeeds Damian deGoa who will remain a director of the Company […]
– Addition to management team brings experienced strategic legal counsel as Company nears pivotal milestones – ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022. Mr. Looker will serve as a […]
Study evaluates obicetrapib, a novel cholesteryl ester transfer protein (CETP) inhibitor, as an adjunct to diet and maximally tolerated lipid-lowering therapy Company is expected to complete enrollment in 2022 and announce data in the first quarter of 2024 NAARDEN, Netherlands–(BUSINESS WIRE)–NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research […]
SHANGHAI, Jan. 1, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in treatment for cardiopulmonary disease, today announced the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study, being the first global completed pulmonary hypertension treatment device RCT study. PADN is an innovative radiofrequency ablation technique in treating PH, was […]
DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Surgical Key Opinion Leaders (KOLs) Alan P. Kypson, M.D., FACS; Luigi Pascarella, M.D., FACS; and Todd E. Rasmussen, M.D., […]
SUZHOU, China, Dec. 30, 2021 /PRNewswire/ — On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement (“TSMVR”) technology was successfully carried out in Asia. The implantation of Peijia’s Highlife TSMVR system was performed by Professor Mao Chen and his team of West China Medical Center of Sichuan University as part of a research clinical […]
SUZHOU, China, Dec. 29, 2021 /PRNewswire/ — SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical. With this win-win collaboration, SyMap has full rights to utilize all assets of Pythagoras, including their Renal Nerve Mapping System (ConfidenHT™, CE Mark Approval,) patents, trademarks and expertise. This collaboration will further enhance and consolidate […]
Acarix AB (”Acarix” or the “Company”) has, as previously announced, completed the rights issue of shares amounting to approximately SEK 79.3 million (the ”Rights Issue”), which was announced on 5 November 2021 and the outcome of the Rights Issue was announced on 20 December 2021. In connection herewith, the board […]
To date, the foundation has funded $15 million of research into congenital heart defects–America’s most common birth defect. NORTHBROOK, Ill., Dec. 28, 2021 /PRNewswire/ — The Children’s Heart Foundation (CHF), the nation’s leading organization dedicated to funding congenital heart defect (CHD) research, will fund over $1,000,000 of research and scientific collaborations in 2021. Every 15 minutes […]
